PKM2 is dispensable for the proliferation, activation, differentiation and antitumor capacity of TCRαβ(+)T cells

ZHU Fang-ming, HAN Yi-chao, LIU Xin-nan, et al

PDF(1578 KB)
Welcome to Current Immunology, Today is
PDF(1578 KB)
Current Immunology ›› 2020, Vol. 40 ›› Issue (4) : 272-280.

PKM2 is dispensable for the proliferation, activation, differentiation and antitumor capacity of TCRαβ(+)T cells

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2020, 40(4): 272-280

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1578 KB)

Accesses

Citation

Detail

Sections
Recommended

/